EASTERN COOPERATIVE ONCOLOGY GROUP

本补助金延续申请的具体目标是 为马约诊所继续参与东部 肿瘤学合作组的活动旨在 了解癌症和癌症相关问题， 发展改进的癌症治疗方案和癌症 患者生存率。 具有重大意义的小组活动继续进行 包括改进诊断程序的发展， 新的癌症化疗药物的研究， 综合治疗的价值和新的治疗方案。 与以前一样，重点将放在直接的病人护理上， 主要的门诊设置。 持续关注和 参与与流行病学研究有关的小组活动， 自然史和特定肿瘤的生物学模式将 尽可能提供。 随着新患者的增加 扩大马约医疗实践的资源， 继续NCCTG活动，我们预计，我们将 超过了我们之前的协议条目和科学贡献。 我们希望继续参与疾病特异性 委员会的活动，新方案设计的评价， 治疗方案和这种管理作用， 任命和适当的。 这种ECOG联系和治疗 已经发展的项目为马约提供了主要的好处， 研究人员，NCCTG的成员，他们的区域癌症 项目，以及参与其中的大量癌症患者 这些研究活动。

The specific objective of this grant continuation application is to provide for Mayo Clinic's continued participation in the Eastern Cooperative Oncology Group activities directed at a greater understanding of cancer and cancer related problems and the development of improved cancer treatment programs and cancer patient survival. Group activities of major importance continue to include the development of improved diagnostic procedures, the study of new cancer chemotherapy agents, and the identification of the value of combined modality therapy and new treatment regimens. Emphasis as before will be placed on direct patient care in a predominant out patient clinic setting. Continued interest and participation in Group activities relate to epidemiologic studies, natural history, and biologic patterns of specific neoplasms will be provided as possible. With the addition of new patient resources in the expansion of the Mayo medical practice and continuing NCCTG activities we would anticipate that we would exceed our previous protocol entry and scientific contribution. We would hope to continue to participate in disease specific committee activities, the evaluation of new protocol design and treatment regimens and such administrative roles as might be appointed and appropriate. This ECOG affiliation and the treatment programs which have evolved, provide major benefits to Mayo, its investigators, the members of NCCTG, their regional cancer programs, and the large group of cancer patients who are involved in these research activities.